<DOC>
	<DOC>NCT02232763</DOC>
	<brief_summary>The investigators hypothesize that using Losartan would help decrease proteinuria in pediatric chronic kidney disease with tubular proteinuria.</brief_summary>
	<brief_title>Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age: 2years or older and younger than 18 years estimated GFR â‰¥ 30mL/min/m^2 Mean urinary proteincreatinine ratio &gt; 0.3 g/g from three firstmorning spot urine collections Renal hypoplasia/dysplasia, Reflux nephropathy, Polycystic kidney disease, Lowe syndrome, Dent disease, Tubulointerstitial nephritis, Nephronophthisis/Medullary cystic disease, Obstructive uropathy(including PUV, UPJ obstruction, UVJ obstruction) hypertension under dialysis or organ transplanted bilateral renal artery stenosis or primary hyperaldosteronism pregnant or nursing</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Losartan</keyword>
	<keyword>children</keyword>
	<keyword>proteinuria</keyword>
</DOC>